These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28990747)

  • 1. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?
    Sarnak DO; Squires D; Kuzmak G; Bishop S
    Issue Brief (Commonw Fund); 2017 Oct; 2017():1-14. PubMed ID: 28990747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription drug accessibility and affordability in the United States and abroad.
    Morgan S; Kennedy J
    Issue Brief (Commonw Fund); 2010 Jun; 89():1-12. PubMed ID: 20614652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.
    Morgan SG; Lee A
    BMJ Open; 2017 Jan; 7(1):e014287. PubMed ID: 28143838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.
    Kanavos P; Ferrario A; Vandoros S; Anderson GF
    Health Aff (Millwood); 2013 Apr; 32(4):753-61. PubMed ID: 23569056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.
    Morgan SG; Good CB; Leopold C; Kaltenboeck A; Bach PB; Wagner A
    Health Policy; 2018 Sep; 122(9):1012-1017. PubMed ID: 30041827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting out-of-pocket requirements: trends in spending, financial access barriers, and policy in ten high-income countries.
    Rice T; Quentin W; Anell A; Barnes AJ; Rosenau P; Unruh LY; van Ginneken E
    BMC Health Serv Res; 2018 May; 18(1):371. PubMed ID: 29776404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.
    Morgan SG; Leopold C; Wagner AK
    CMAJ; 2017 Jun; 189(23):E794-E799. PubMed ID: 28606975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Spending in the United States and Other High-Income Countries.
    Papanicolas I; Woskie LR; Jha AK
    JAMA; 2018 Mar; 319(10):1024-1039. PubMed ID: 29536101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22619775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22582452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U.S. health care from a global perspective: spending, use of services, prices, and health in 13 countries.
    Squires D; Anderson C
    Issue Brief (Commonw Fund); 2015 Oct; 15():1-15. PubMed ID: 26591905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
    Raimond VC; Feldman WB; Rome BN; Kesselheim AS
    Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease.
    Hennessy D; Sanmartin C; Ronksley P; Weaver R; Campbell D; Manns B; Tonelli M; Hemmelgarn B
    Health Rep; 2016 Jun; 27(6):3-8. PubMed ID: 27305075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
    Wineinger NE; Zhang Y; Topol EJ
    JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International prices and availability of pharmaceuticals in 2005.
    Danzon PM; Furukawa MF
    Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Prescription Drug Spending Leading Up to Health Reform.
    Blavin F; Waidmann T; Blumberg LJ; Roth J
    Med Care Res Rev; 2014 Aug; 71(4):416-32. PubMed ID: 24830379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.